Real‐time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes
Acta Physiologica · 2025
DOI: 10.1111/apha.14268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2025. Verfasst von Mingyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Somatostatin, Diabetes Mellitus, Type 2, Islets of Langerhans. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Leona M. and Harry B. Helmsley Charitable Trust, Novo Nordisk Fonden.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Somatostatin from pancreatic δ‐cells is a paracrine regulator of insulin and glucagon secretion, but the release kinetics and whether secretion is altered in diabetes is unclear. This study aimed to improve understanding of somatostatin secretion by developing a tool for real‐time detection of somatostatin release from individual pancreatic islets.
Methods
Reporter cells responding to somatostatin with cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) changes were generated by co‐expressing somatostatin receptor SSTR2, the G‐protein Gα15 and a fluorescent Ca 2+ sensor in HeLa cells.
Results
Somatostatin induced dose‐dependent [Ca 2+ ] i increases in reporter cells with half‐maximal and maximal effects at 1.6 ± 0.4 and ~30 nM, respectively. Mouse and human islets induced reporter cell [Ca 2+ ] i elevations that were inhibited by the SSTR2 antagonist CYN154806. Depolarization of islets by high K + , K ATP channel blockade or increasing the glucose concentration from 3 to 11 mM evoked concomitant elevations of [Ca 2+ ] i in islets and reporter cells. Exposure of islets to glucagon, GLP‐1 and ghrelin also triggered reporter cell [Ca 2+ ] i responses, whereas little effect was obtained by islet exposure to insulin, glutamate, GABA and urocortin‐3. Islets from type 2 diabetic human donors induced higher reporter cell [Ca 2+ ] i responses at 11 mM and after K + depolarization compared with non‐diabetic islets, although fewer δ‐cells were identified by immunostaining.
Conclusion
Type 2 diabetes is associated with hypersecretion of somatostatin, which has implications for paracrine regulation of insulin and glucagon secretion. The new reporter cell assay for real‐time detection of single‐islet somatostatin release holds promise for further studies of somatostatin secretion in islet physiology and pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Özge Dumral, Anders Tengholm
Förderung
- Vetenskapsrådet
- Leona M. and Harry B. Helmsley Charitable Trust
- Novo Nordisk Fonden
- Diabetesfonden
- Barndiabetesfonden
- Insamlingsstiftelsen Diabetes Wellness Network Sverige
- Stiftelsen Familjen Ernfors Fond
- Nils Erik Holmstens forskningsstiftelse
Zitieren
APA
Yang, M., Mandal, K., Södergren, M., Dumral, Ö., Winroth, L., & Tengholm, A. (2025). Real‐time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes. Acta Physiologica. https://doi.org/10.1111/apha.14268
Vancouver
Yang M, Mandal K, Södergren M, Dumral Ö, Winroth L, Tengholm A. Real‐time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes. Acta Physiologica. 2025. doi:10.1111/apha.14268
BibTeX
@article{Yang2025,
author = {Yang, Mingyu and Mandal, Kousik and Södergren, Moa and Dumral, Özge and Winroth, Lena and Tengholm, Anders},
title = {Real‐time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes},
journal = {Acta Physiologica},
year = {2025},
doi = {10.1111/apha.14268}
}
EUVIMED